A Phase 1, Open-Label, Single Center, Single-Dose, Randomized, 4-Way Crossover Study to Assess the Effect of an Antacid on the Bioavailability of Febuxostat After Oral Administration of a 80 mg Febuxostat Extended-Release (XR) Capsule Formulation
收藏DataCite Commons2025-12-03 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00003346/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to assess the effect of antacid administration, and its timing, on the bioavailability of a single dose of febuxostat extended-release (XR) 80 mg.
提供机构：
Vivli
创建时间：
2019-03-06
